Aerosol Therapy for Pneumonia in the Intensive Care Unit
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 39 (4) , 823-836
Abstract
No abstract availableKeywords
Funding Information
- Bayer HealthCare
This publication has 78 references indexed in Scilit:
- Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective studyBMC Anesthesiology, 2013
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-RegressionClinical Infectious Diseases, 2012
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic ReviewAnnals of Intensive Care, 2012
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining FluidClinical Pharmacokinetics, 2011
- Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteriaJournal of Hospital Infection, 2011
- Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated PneumoniaAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumoniaCritical Care, 2009
- In Vitro / In Vivo Comparisons in Pulmonary Drug DeliveryJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Comparative Analysis of Methods to Measure Aerosols Generated by a Vibrating Mesh NebulizerJournal of Aerosol Medicine, 2007
- Effective inhaled drug administration to mechanically ventilated patientsExpert Opinion on Drug Delivery, 2006